St. Francis Cancer Center | St. Francis Cancer Center | CC-5013-DLC-002 (ROBUST)
st francis cancer center, cancer center greenville sc, cancer care greenville sc, aya cancer care, aya cancer care greenville sc
1275
clinical-trial-template-default,single,single-clinical-trial,postid-1275,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-3.2,wpb-js-composer js-comp-ver-4.12,vc_responsive

Clinical Trials

CC-5013-DLC-002 (ROBUST)

Efficacy and safety study to compare Lenalidomide (CC-55013) plus R-CHOP Chemotherapy (R2-CHOP) versus Placebo plus R-CHOP Chemotherapy in subjects with previously untreated Activated B-Cell Type Diffuse Large B-Cell Lymphoma (ROBUST) Read More >

« Available Clinical Trials